Cullen/Frost Bankers’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Cullen/Frost Bankers’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-28	Closed	-$1.2K	–	1218
2023 Q3	$1.2K	Hold	28	–	–	﹤0.01%	1099
2023 Q2	$1.18K	Buy	+28	New	+$1.13K	﹤0.01%	1078
2022 Q2	–	Sell	-12	Closed	-$1K	–	1222
2022 Q1	$1K	Hold	12	–	–	﹤0.01%	1143
2021 Q4	$1K	Buy	+12	New	+$1.15K	﹤0.01%	1170

Other funds holding SYNH

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Cullen/Frost Bankers's SYNH Position: Q4 2023 in Review

Cullen/Frost Bankers sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2023, closing a stake of 28 shares — an estimated $1.2K sold.

Cullen/Frost Bankers first reported a position in SYNH in Q4 2021 and held it in 4 quarters. The position peaked at $1.2K in Q3 2023. 2 funds tracked by Wall St. Rank hold SYNH as of Q4 2023.

Cullen/Frost Bankers reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
Cullen/Frost Bankers sold 28 Syneos Health, Inc. Class A Common Stock shares in Q4 2023, an estimated $1.2K.
Cullen/Frost Bankers first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 4 quarters.
Cullen/Frost Bankers's Syneos Health, Inc. Class A Common Stock position peaked at $1.2K in Q3 2023.
2 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2023.

Based on Cullen/Frost Bankers's 13F filing for Q4 2023, filed 6 Feb 2024.